Organic compounds -- part of the class 532-570 series – Organic compounds – Hydroxamic acids – chalcogen analogs or salts thereof
Reexamination Certificate
2007-06-26
2007-06-26
Witherspoon, Sikarl A. (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Hydroxamic acids, chalcogen analogs or salts thereof
C514S307000, C514S575000
Reexamination Certificate
active
10541795
ABSTRACT:
Compounds of formula (I), inhibit TNFα production and may therefore be useful in the treatment of inflammation, of auto-immune diseases, and of pathological conditions which involve excessive production of that cytokine. The compounds of formula (I) are also inhibitors of the histone deacetylase enzyme and may therefore be useful in tumorous diseases, alone or in association with other anti-tumor active ingredients
REFERENCES:
patent: 6034096 (2000-03-01), Bertolini et al.
patent: WO 96/15105 (1996-05-01), None
patent: WO 97/43251 (1997-11-01), None
patent: WO 02/055017 (2002-07-01), None
patent: WO 03/013493 (2003-02-01), None
Chemical Abstracts Service; Fujii, Setsuro et al; “trans-4-Aminomethylcyclohexane hydroxamic acid”; Database Accession No. 87:39013; Pharmaceutical Co. Ltd., Japan; (2 pgs) XP-002278214, 1977.
Uesato, S., et al; “Novel Histone Deacetylase Inhibitors: N-Hydroxycarboxamides Possessing a Terminal Bicyclic Aryl Group”;Bioorganic&Medical Chemistry Letters; vol. 12; pp. 1347-1394 (2002).XP-002276408.
Richon, V.M., et al; “A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases”;Proc. Natl. Acad. Sci.; vol. 95; pp. 3003-3007 (1998) XP-001120542.
Bouchain, G., et al; “Development of Potential Antitumor Agents, Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors”;J. Med. Chem.; vol. 46; pp. 820-830 (2003) XP-002278212.
Lu, Q., et al; Zn2+-Chelating Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase Inhibitors;J. Med. Chem.; vol. 47, pp. 467-474 (2004) XP-002278213.
Mascagni Paolo
Mazzaferro Rocco
Pinori Massimo
Vergani Barbara
Italfarmaco SpA
Nixon & Vanderhye
Witherspoon Sikarl A.
LandOfFree
Hydroxamic acid derivatives having anti-inflammatory action does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid derivatives having anti-inflammatory action, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid derivatives having anti-inflammatory action will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3849504